首页> 外文OA文献 >METHYLENE CHLORIDE EXPOSURE EVALUATION DURING ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURING
【2h】

METHYLENE CHLORIDE EXPOSURE EVALUATION DURING ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURING

机译:活性药物成分制造过程中亚甲基氯的暴露评估

摘要

A manufacturer utilizes methylene chloride (CH2Cl2) (CAS 75-09-2), also known as dichloromethane, to manufacture active pharmaceutical ingredients. Methylene chloride is specifically regulated by the Occupational Safety and Health Administration (OSHA) under 29 Code of Federal Regulation (CFR) 1910.1052. Evaluation and documentation of employee exposure to methylene chloride is required to comply with OSHA regulations. In addition to OSHA compliance, it is also important to evaluate employee exposure levels to determine if respiratory protection, regulation of the work area, and medical monitoring are necessary.This industrial hygiene report describes an investigation into the risks of exposure to methylene chloride. This report includes evaluation of employee exposure to methylene chloride during the manufacture of active pharmaceutical ingredients. During the manufacture of active pharmaceutical ingredients, employees transfer methylene chloride from small containers to a large reactor. After the desired reaction has taken place and allowed to separate, different layers of the solution which contains methylene chloride are drained from the reactor into small containers. Employees have the potential for exposure to methylene chloride during the transfer and collection processes.The results of the occupational exposure sampling indicate employees are exposed to levels of methylene chloride above the permissible exposure limit (PEL) and the action limit (AL). The regulatory standard requires medical monitoring when employees are exposure above the AL. Regulation of the work area and respiratory protection is required at the PEL.Recommendations to reduce exposure include identifying a substitute solvent that is less hazardous. To control exposure through an engineering control, an evaluation of the current localized ventilation system would be valuable in determining existing capabilities for reducing exposure to methylene chloride vapors. If this is not possible with the current ventilation system, other ventilation options could be explored. An engineering control to reduce exposure during methylene chloride transfer from pails to the reactor may be achieved by applying nitrogen pressure to the bucket to force methylene chloride from one container to the reactor vessel from a remote location. Reduction of exposure during transfer from the bottom of the reactor to collection pails may be achieved by attaching a hose to the bottom of the reactor and channeling discharge into a closed top container. The implementation of either of these controls would necessitate additional exposure monitoring to evaluate the effectiveness.
机译:制造商利用二氯甲烷(CH2Cl2)(CAS 75-09-2)(也称为二氯甲烷)制造活性药物成分。根据美国联邦法规(CFR)29 1910.1052,职业安全与健康管理局(OSHA)专门对二氯甲烷进行监管。必须对员工接触二氯甲烷进行评估和记录,以符合OSHA法规。除了符合OSHA规定外,评估员工的暴露水平也很重要,以确定是否有必要进行呼吸防护,工作区域调节和医疗监控。该工业卫生报告描述了对暴露于二氯甲烷中的风险的调查。该报告包括对员工在生产活性药物成分过程中接触二氯甲烷的评估。在生产活性药物成分期间,员工将二氯甲烷从小容器转移到大反应器中。进行所需的反应并使其分离后,将含有二氯甲烷的溶液的不同层从反应器中排入小容器中。员工在转移和收集过程中可能会接触到二氯甲烷。职业接触抽样的结果表明,员工所接触的二氯甲烷水平超过允许的接触限值(PEL)和操作限值(AL)。当员工暴露在AL之上时,监管标准要求进行医疗监控。 PEL要求对工作区域和呼吸防护进行规定。减少接触的建议包括确定危害较小的替代溶剂。为了通过工程控制来控制暴露,对当前局部通风系统的评估对于确定减少暴露于二氯甲烷蒸气的现有能力将是有价值的。如果当前的通风系统无法做到这一点,则可以探索其他通风选择。可以通过向桶施加氮气压力以迫使二氯甲烷从一个容器从远程位置到反应器容器的方式来进行工程控制,以减少二氯甲烷从桶转移到反应器期间的暴露。通过将软管附接到反应器的底部并将排放物引导到密闭的顶部容器中,可以减少从反应器的底部到收集桶的转移期间的暴露。这些控制措施之一的实施将需要额外的暴露监测以评估有效性。

著录项

  • 作者

    Rullman Janet;

  • 作者单位
  • 年度 2015
  • 总页数
  • 原文格式 PDF
  • 正文语种
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号